Summary
The effects of Trichostatin A (TSA) on histone deacetylase 8 (HDAC8) expression, proliferation and cell cycle arrest in T-lymphoblastic leukemia cell line Molt-4 cells in vitro were investigated. The effect of TSA on the growth of Molt-4 cells was studied by MTT assay. Flow cytometry was used to examine the cell cycle. The expression of HDAC8 was detected by using immunocytochemistry and Western blot. The results showed that proliferation of Molt-4 cells was inhibited in TSA-treated group in a time-and dose-dependent manner. The IC50 of TSA exposures for 24 h and 36 h were 254.3236 and 199.257 μg/L respectively. The cell cycle analysis revealed that Molt-4 was mostly in G0/G1 phase, and after treatment with TSA from 50 to 400 μg/L for 24 h, the percents of G0/G1 cells were decreased and cells were arrested in G2/M phase. Treatment of TSA for 24 h could significantly inhibit the expression of HDAC8 protein in Molt-4 cells (P<0.01). It was concluded that TSA could decrease the expression of HDAC8 in Molt-4 cells, which contributed to the inhibition of proliferation and induction of cell cycle arrest in Molt-4 cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Monneret C. Histone deacetylase inhibitors. Eur J Med Chem, 2005,40:1–13
Vanhaecke T, Papeleu P, Elaut G et al. Trichostatin A-like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr Med Chem, 2004,11:1629–1643
Vannini A, Volpari C, Filocamo G et al. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci U S A, 2004,101:15 064–15 069
Liu H, Chen Y, Cui G et al. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation effect. Acta Pharmacol Sin, 2005,26:603–609
Buggy J J, Sideris M L, Mark P et al. Cloning and characterization of a novel human histone deacetylase, HDAC8. Biochem J, 2000,350 Pt 1:199–205
Van den Wyngaert I, de Vries W, Kremer A et al. Cloning and characterization of human histone deacetylase 8. FEBS Lett, 2000,478:77–83
Hu E, Chen Z, Fredrickson T et al. Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem, 2000,275:15 254–15 264
Waltregny D, De Leval L, Glenisson W et al. Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues. Am J Pathol, 2004,165:553–564
Durst K L, Lutterbach B, Kummalue T et al. The inv(16) fusion protein associates with corepressors via a smooth muscle myosin heavy-chain domain. Mol Cell Biol, 2003,23:607–619
Thakur A, Xu H, Wang Y et al. The role of X-linked genes in breast cancer. Breast Cancer Res Treat, 2005,93:135–143
Song Y, Liu M J, Zhao G W et al. The mechanism of P21WAF1/Cip-1 expression in Molt-4 cell line induced by TSA (Chinese). J Exp Hematology, 2005,13:174–181
Yoshida M, Furumai R, Nishiyama M et al. Histone deacetylase as a new target for cancer chemotherapy. Cancer Chemother Pharmacol, 2001, 48(Suppl 1):S20–S26
Author information
Authors and Affiliations
Additional information
This project was supported by a grant from National Natural Sciences Foundation of China (No. 30271672).
Rights and permissions
About this article
Cite this article
He, J., Liu, H. & Chen, Y. Effects of trichostatin A on HDAC8 expression, proliferation and cell cycle of Molt-4 cells. J. Huazhong Univ. Sc. Technol. 26, 531–533 (2006). https://doi.org/10.1007/s11596-006-0511-x
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11596-006-0511-x